Call Us: 888-488-5750

Seeing the future of self-insurance

VativoRx recently participated in the SIIA Future Leaders Forum in April 2022.

The goal of the Forum: Identify both the issues and opportunities for self-insurance in the coming years, and the people who are best-suited to help the industry address those opportunities.

The Forum saluted the people who got the self-insurance industry to its current position while beginning the important conversations around what comes next. 

VativoRx was proud to send one of our best people to the conference: Rosalyn Banks.

As director of PBM Programs & Services at VativoRx, Rosalyn oversees our company operations, the daily operations of staff and supervises all aspects of prescription benefit management (PBM) functions. This includes claims processing, plan management, customer service, client management, consulting resources, Rx audits & fraud/abuse identification and drug utilization review programs.

Rosalyn reports it was energizing to be around so many people in one place that are focused intently on the future.

A New 340B Pilot Signals a Shift in Strategic Rebate Management

On August 1, 2025, the Centers for Medicare & Medicaid Services (CMS) announced the application process for the 340B Rebate Model Pilot Program, a move that may redefine how providers access cost relief under the 340B program. Instead of traditional point-of-sale discounts, this pilot will allow for rebates after purchase for covered outpatient drugs reimbursed under Medicaid.

Read More »

Rebate Audits Are On the Rise—Is Your Program Ready?

As healthcare organizations look to rebate programs to offset tightening margins, audit readiness is becoming a strategic necessity.

Increased scrutiny from manufacturers and evolving requirements around documentation, PHI use, and clinical coding are shifting rebate submissions from “nice-to-have” to regulated deliverables.

Read More »